Order Article Reprints

Bertrand J, Dostálová H, Kryštof V, Jorda R, Delgado T, Castro-Alvarez A, Mella J, Cabezas D, Faúndez M, Espinosa-Bustos C, et al. Design, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia. Pharmaceutics. 2022; 14(6):1294. https://doi.org/10.3390/pharmaceutics14061294

Bertrand, Jeanluc, Hana Dostálová, Vladimír Kryštof, Radek Jorda, Thalía Delgado, Alejandro Castro-Alvarez, Jaime Mella, David Cabezas, Mario Faúndez, Christian Espinosa-Bustos, and et al. 2022. "Design, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia" Pharmaceutics 14, no. 6: 1294. https://doi.org/10.3390/pharmaceutics14061294

Bertrand, J., Dostálová, H., Kryštof, V., Jorda, R., Delgado, T., Castro-Alvarez, A., Mella, J., Cabezas, D., Faúndez, M., Espinosa-Bustos, C., & Salas, C. O. (2022). Design, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia. Pharmaceutics, 14(6), 1294. https://doi.org/10.3390/pharmaceutics14061294